# The future of cancer treatment and immunotherapy with researcher Dr. Alicia Zhou

Page: https://stenobird.com/podcast/ted-health-388141/the-future-of-cancer-treatment-and-immunotherapy-with-researcher-dr-alicia-zhou
Text version: https://stenobird.com/podcast/ted-health-388141/the-future-of-cancer-treatment-and-immunotherapy-with-researcher-dr-alicia-zhou.md
Podcast: [TED Health](https://stenobird.com/podcast/ted-health-388141)
Published: 2026-06-02T04:00:00+00:00
Episode link: https://audiocollective.ted.com
Audio file: https://sphinx.acast.com/p/open/s/67585b08102e6d4448d360b1/e/6a0def09d7997e788cfeebe5/media.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/ted-health-388141/episodes/the-future-of-cancer-treatment-and-immunotherapy-with-researcher-dr-alicia-zhou
Duration seconds: 1776

## Resource

Dr. Alicia Zhou is the Chief Executive Officer of the Cancer Research Institute—the oldest nonprofit in the world devoted exclusively to cancer immunology and immunotherapy. She joins Shoshana to discuss the innovations happening in cancer research, how immunotherapy is different from chemotherapy and radiation, what doctors can do to make clinical trials less intimidating, and why the conversation around cancer will change in the next 10 years. Hosted on Acast. See acast.com/privacy for more information.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/ted-health-388141/episodes/the-future-of-cancer-treatment-and-immunotherapy-with-researcher-dr-alicia-zhou/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/ted-health-388141/the-future-of-cancer-treatment-and-immunotherapy-with-researcher-dr-alicia-zhou.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.